Lot 28
American (b. 1928)
Spring Woods - New Jersey (1974-5)
Medium

oil on canvas

Dimensions

13 x 18 inches

Signature

signed lower left

Estimate: $3,000 - $5,000

Price Realized: $4,608
Includes buyer's premium

Have one like this?

Frame Information

frame dimensions: 18 x 23 x 2 inches, wood frame

Provenance

From the Collection of Memorial Sloan Kettering Cancer Center

Condition

overall good condition, medium is well attached to the support

Paul Resika

American b. 1928

Paul Resika is regarded as an important figure in American art, particularly in the realm of contemporary painting.  Resika's distinctive style, often characterized by bold colors, expressive brushwork, and a unique approach to form and composition, has garnered attention and admiration within the art world. His work often explores the intersection between abstraction and representation, offering viewers a fresh perspective on familiar subjects. Resika's work often engages with broader artistic and cultural themes, through his exploration of color, form, and subject matter, he enriches the artistic landscape and invites viewers to contemplate deeper meanings within his paintings.

A selection from

Memorial Sloan Kettering Cancer Center

Image for Collection Memorial Sloan Kettering Cancer Center

Proceeds from this sale will directly benefit The Society of MSK, which was founded in 1946 by a group of forward-thinking women dedicated to enhancing the hospital environment and level of patient support that have always been the hallmarks of MSK. Today, the Society has evolved into a full partner of MSK as an internationally renowned organization involved in both policy and fundraising in support of research, patient care programs and education. 


Memorial Sloan Kettering Cancer Center is the world's oldest and largest private cancer center, providing comprehensive care to patients from all walks of life. Renowned for its cutting-edge research, innovative treatments, and compassionate approach to care, Memorial Sloan Kettering Cancer Center is dedicated to making progress against cancer and improving outcomes for patients worldwide.